D. Western Therapeutics Institute
4576
Needs Well
3992
Daiwa Cycle
5888
Osaka Yuka Industry
4124
Liberta
4935
(FY)Mar 31, 2024 | (FY)Mar 31, 2023 | |
---|---|---|
Operating cash flow (Indirect Method) | ||
Cash from operating activities | 193.26%10.98B | 3.74B |
Net profit before non-cash adjustment | 307.61%908.1M | --222.79M |
Total adjustment of non-cash items | 28.91%4.81B | --3.73B |
-Depreciation and amortization | -4.23%3.32B | --3.46B |
-Reversal of impairment losses recognized in profit and loss | 392.82%1.16B | --235.29M |
-Share of associates | 176.35%27.62M | --9.99M |
-Disposal profit | -0.24%432.41M | --433.43M |
-Other non-cash items | 69.11%-126.92M | ---410.87M |
Changes in working capital | 2,638.30%5.27B | ---207.46M |
-Change in receivables | 43.25%-267.27M | ---471M |
-Change in inventory | 185.20%61.18M | ---71.8M |
-Change in payables | 1,338.33%3.31B | --230.37M |
-Change in accrued expense | 24.74%-126.24M | ---167.72M |
-Provision for loans, leases and other losses | 82.06%58.27M | --32.01M |
-Changes in other current assets | 101.46%7.31M | ---502.04M |
-Changes in other current liabilities | 198.79%2.22B | --742.73M |
Dividends paid (cash flow from operating activities) | ||
Dividends received (cash flow from operating activities) | ||
Interest paid (cash flow from operating activities) | 0.46%-322.45M | -323.93M |
Interest received (cash flow from operating activities) | -0.93%10.78M | 10.88M |
Tax refund paid | -10.64%-365.76M | -330.57M |
Other operating cash inflow (outflow) | -94.78%22.85M | 437.65M |
Operating cash flow | 191.83%10.33B | --3.54B |
Investing cash flow | ||
Net PPE purchase and sale | -27.03%-3.32B | ---2.61B |
Net intangibles purchase and sale | 31.18%-143.38M | ---208.35M |
Net business purchase and sale | --0 | --45.47M |
Net investment product transactions | -1,004.98%-10M | --1.11M |
Net changes in other investments | 35.07%411.74M | --304.83M |
Investing cash flow | -23.93%-3.06B | ---2.47B |
Financing cash flow | ||
Net issuance payments of debt | -15,699.23%-3B | ---19.01M |
Net common stock issuance | --32.93M | --0 |
Increase or decrease of lease financing | 23.71%-746.07M | ---977.99M |
Cash dividends paid | -60.90%-237.51M | ---147.61M |
Net other fund-raising expenses | -57,555,800.00%-575.56M | ---1K |
Financing cash flow | -295.77%-4.53B | ---1.14B |
Net cash flow | ||
Beginning cash position | -2.78%2.69B | --2.76B |
Current changes in cash | 3,662.97%2.73B | ---76.76M |
End cash Position | 101.77%5.42B | --2.69B |
Free cash flow | 888.03%6.86B | --694.37M |
Currency Unit | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP |